Early detection of graft failure using the blood metabolic profile of a liver recipient

被引:78
作者
Serkova, Natalie J.
Zhang, Yu
Coatney, John L.
Hunter, Lawrence
Wachs, Michael E.
Niemann, Claus U.
Mandell, M. Susan
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Radiol, Biomed MRI MRS Canc Ctr Ctr Core, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Div Bioinformat, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Surg, Div Transplantat, Denver, CO 80262 USA
[4] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Surg, Div Transplantat, San Francisco, CA 94143 USA
关键词
primary graft dysfunction; living-related liver transplantation; metabolomics; H-1-NMR spectroscopy;
D O I
10.1097/01.tp.0000251649.01148.f8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
In this case report we describe the blood metabolic profile ("metabolomics") by nuclear magnetic resonance (NMR) spectroscopy and principle component analysis (PCA) from a patient who underwent two consecutive liver transplantations. The first graft from a living-related donor failed and was followed by a second successful transplant from a deceased donor. Using quantitative high-resolution H-1-NMR spectroscopy, 48 endogenous metabolites were analyzed in whole blood samples at baseline and different time points after each transplantation. From 48 analyzed metabolites, six metabolites were identified by PCA as metabolic markers consistent with a non-functional liver after first transplantation. Importantly, this distinctive metabolic profile was present as early as two hours after first transplant surgery when no other variable or conventional laboratory tests indicated poor graft function. This article reports the potential usefulness of quantitative H-1-NMR based metabolomics to diagnose early graft dysfunction in liver transplantation.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 17 条
[1]
Organ donation and utilization in the United States, 2004 [J].
Delmonico, FL ;
Sheehy, E ;
Marks, WH ;
Baliga, P ;
McGowan, JJ ;
Magee, JC .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (04) :862-873
[2]
Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts [J].
Fuller, TF ;
Serkova, N ;
Niemann, CU ;
Freise, CE .
JOURNAL OF UROLOGY, 2004, 171 (03) :1296-1300
[3]
Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury [J].
Hauet, T ;
Baumert, H ;
Gibelin, H ;
Hameury, F ;
Goujon, JM ;
Carretier, M ;
Eugene, M .
CRYOBIOLOGY, 2000, 41 (04) :280-291
[4]
Chemometric models for toxicity classification based on NMR spectra of biofluids [J].
Holmes, E ;
Nicholls, AW ;
Lindon, JC ;
Connor, SC ;
Connelly, JC ;
Haselden, JN ;
Damment, SJP ;
Spraul, M ;
Neidig, P ;
Nicholson, JK .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (06) :471-478
[5]
Combination of 'omics' data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers [J].
Kleno, TG ;
Kiehr, B ;
Baunsgaard, D ;
Sidelmann, UG .
BIOMARKERS, 2004, 9 (02) :116-138
[6]
Principal component analysis for predicting transcription-factor binding motifs from array-derived data [J].
Liu, YL ;
Vincenti, MP ;
Yokota, H .
BMC BIOINFORMATICS, 2005, 6 (1)
[7]
Elimination of indocyanine green in the perioperative evaluation of donor liver function [J].
Mandell, MS ;
Wachs, M ;
Niemann, CU ;
Henthorn, TK .
ANESTHESIA AND ANALGESIA, 2002, 95 (05) :1182-1184
[8]
Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity [J].
Mortishire-Smith, RJ ;
Skiles, GL ;
Lawrence, JW ;
Spence, S ;
Nicholls, AW ;
Johnson, BA ;
Nicholson, JK .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (02) :165-173
[9]
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data [J].
Nicholson, JK ;
Lindon, JC ;
Holmes, E .
XENOBIOTICA, 1999, 29 (11) :1181-1189
[10]
The MEGX test: A tool for the real-time assessment of hepatic function [J].
Oellerich, M ;
Armstrong, VW .
THERAPEUTIC DRUG MONITORING, 2001, 23 (02) :81-92